Healthcare's Bio/Pharma-Fueled Bull Continues; But
its advance has effectively stalled just above it's Deep Crab PRZ, and at a confluence of APF and structured resistance. Reflecting the ebb in momentum, XLV's rate-of-change is at its lowest since December 2012.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.